gabapentin + placebo

Gabapentin + placebo is not a marketed combination drug or unique pharmaceutical product. Instead, this term refers to the use of gabapentin and an inert substance (placebo) in clinical trial settings, where one group receives gabapentin and another receives a placebo for comparison. Gabapentin is an anticonvulsant and neuropathic pain agent that acts by modulating voltage-gated calcium channels, specifically binding to the alpha-2-delta subunit, thereby reducing excitatory neurotransmitter release. Placebo contains no active pharmacological ingredient and serves as a control in randomized controlled trials to assess the efficacy and safety of gabapentin[1][3][6]. This combination is used exclusively for research purposes to evaluate treatment effects.